MA25656A1 - A METHOD FOR MAINTAINING OR IMPROVING MUCIN SYNTHESIS. - Google Patents

A METHOD FOR MAINTAINING OR IMPROVING MUCIN SYNTHESIS.

Info

Publication number
MA25656A1
MA25656A1 MA26798A MA26798A MA25656A1 MA 25656 A1 MA25656 A1 MA 25656A1 MA 26798 A MA26798 A MA 26798A MA 26798 A MA26798 A MA 26798A MA 25656 A1 MA25656 A1 MA 25656A1
Authority
MA
Morocco
Prior art keywords
maintaining
improving
mucin synthesis
disease states
synthesis
Prior art date
Application number
MA26798A
Other languages
French (fr)
Inventor
Olivier Ballevre
Denis Breuille
Paul-Andre Finot
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27052980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA25656(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/774,814 external-priority patent/US6833350B2/en
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MA25656A1 publication Critical patent/MA25656A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Methods for maintaining, improving or increasing the synthesis of mucins by administering a nutritional composition or supplement that contains a therapeutically effective amount of threonine are provided. The present invention further provides methods for treating a variety of disease states characterized by alterations to the mucin levels, such as, intestinal inflammatory and bacterial infections or other like disease states.
MA26798A 2000-02-04 2002-08-30 A METHOD FOR MAINTAINING OR IMPROVING MUCIN SYNTHESIS. MA25656A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49890500A 2000-02-04 2000-02-04
US09/774,814 US6833350B2 (en) 2000-02-04 2001-01-30 Method for maintaining or improving the synthesis of mucins

Publications (1)

Publication Number Publication Date
MA25656A1 true MA25656A1 (en) 2002-12-31

Family

ID=27052980

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26798A MA25656A1 (en) 2000-02-04 2002-08-30 A METHOD FOR MAINTAINING OR IMPROVING MUCIN SYNTHESIS.

Country Status (22)

Country Link
EP (1) EP1255452B2 (en)
JP (1) JP2003533436A (en)
CN (1) CN1434681B (en)
AT (1) ATE323422T1 (en)
AU (1) AU784137B2 (en)
BG (1) BG106967A (en)
BR (1) BRPI0108096B1 (en)
CA (1) CA2399063C (en)
CZ (1) CZ20022978A3 (en)
DE (1) DE60118888T3 (en)
DZ (1) DZ3298A1 (en)
ES (1) ES2261383T5 (en)
HR (1) HRP20020647A2 (en)
HU (1) HUP0204439A3 (en)
IL (1) IL150977A (en)
MA (1) MA25656A1 (en)
MX (1) MXPA02007491A (en)
NO (1) NO20023640L (en)
NZ (1) NZ520605A (en)
PL (1) PL357078A1 (en)
SK (1) SK11212002A3 (en)
WO (1) WO2001056405A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2391558T3 (en) 2003-06-23 2012-11-27 Nestec S.A. Amino acid supplement for a healthy microbiotic ecosystem
JPWO2007004613A1 (en) * 2005-07-01 2009-01-29 味の素株式会社 Inflammatory bowel disease therapeutic agent and TNF-α production inhibitor
CA2631220A1 (en) * 2006-01-09 2007-07-19 Nestec S.A. Treatment of stressed patients
WO2012133198A1 (en) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 Nutritional composition for inflammatory diseases
EP2734210B1 (en) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP3167895A1 (en) * 2015-11-10 2017-05-17 University College Dublin A dietary supplement comprising beta-glucan and casein hydrolysate for improving health and growth performance in a mammal

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459620B1 (en) * 1979-06-26 1983-08-05 Agronomique Inst Nat Rech TOTAL ENZYMATIC HYDROLISATE OF WHEY PROTEINS, OBTAINMENT AND APPLICATION
US5162373A (en) * 1986-01-17 1992-11-10 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
JP2631470B2 (en) * 1987-05-15 1997-07-16 雪印乳業株式会社 Infection protective agent
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JP2805490B2 (en) * 1989-02-07 1998-09-30 雪印乳業株式会社 Bacterial toxin neutralizer
JP3007694B2 (en) * 1990-12-14 2000-02-07 雪印乳業株式会社 Pharmaceuticals and foods for preventing or treating gastric ulcer
ES2173109T3 (en) * 1992-12-23 2002-10-16 Abbott Lab FOODS OF A MEDICAL UNDERSTANDED FOR NUTRITIONAL SUSTAINMENT OF NEWBORNS / BABIES WHO ARE LIVING WITH METABOLIC DISEASES.
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
FR2711529B1 (en) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition based on amino acids intended for the treatment of an infection or an aggression causing an inflammatory reaction, in animals and in humans.
JPH07267855A (en) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk Glutamine producing agent
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
US5670157A (en) * 1995-12-11 1997-09-23 Nestec Ltd. Method for reducing and controlling immunoglobulin concentrations
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
ES2265669T3 (en) * 1997-09-16 2007-02-16 Societe Des Produits Nestle S.A. USE OF A SPECIFIC NUTRITIVE COMPOSITION FOR AN ORGAN.
WO1999067373A2 (en) * 1998-06-24 1999-12-29 Boyce Thompson Institute For Plant Research, Inc. Invertebrate intestinal mucins, cdnas, antibodies and their use
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
WO2001031006A2 (en) * 1999-10-22 2001-05-03 The Board Of Regents Of The University Of Nebraska Serum amyloid a isoform from colostrum

Also Published As

Publication number Publication date
IL150977A (en) 2005-09-25
EP1255452A2 (en) 2002-11-13
ES2261383T3 (en) 2010-06-14
IL150977A0 (en) 2003-02-12
CZ20022978A3 (en) 2003-02-12
BR0108096A (en) 2002-10-29
SK11212002A3 (en) 2003-01-09
CN1434681A (en) 2003-08-06
CN1434681B (en) 2010-12-08
CA2399063A1 (en) 2001-08-09
BG106967A (en) 2003-04-30
EP1255452B1 (en) 2006-04-19
HRP20020647A2 (en) 2004-12-31
AU4056401A (en) 2001-08-14
ES2261383T5 (en) 2010-06-18
NO20023640D0 (en) 2002-07-31
HUP0204439A2 (en) 2003-04-28
EP1255452B2 (en) 2010-03-03
WO2001056405A2 (en) 2001-08-09
BRPI0108096B1 (en) 2017-05-09
HUP0204439A3 (en) 2004-12-28
NZ520605A (en) 2004-06-25
CA2399063C (en) 2014-01-28
PL357078A1 (en) 2004-07-12
DZ3298A1 (en) 2001-08-09
AU784137B2 (en) 2006-02-09
DE60118888T2 (en) 2007-01-18
MXPA02007491A (en) 2002-12-13
ATE323422T1 (en) 2006-05-15
DE60118888D1 (en) 2006-05-24
DE60118888T3 (en) 2010-09-23
JP2003533436A (en) 2003-11-11
NO20023640L (en) 2002-09-19
WO2001056405A3 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
MY139124A (en) Gyrase inhibitors and uses thereof
DE60325945D1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF MICROORGANISM INFECTIONS
CY1110230T1 (en) GRAIN SUSPENSIONS AND THEIR USES
EP1673078A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
IL147271A0 (en) Compounds that bind her2
TW200621766A (en) Substituted hydantoins
WO2001098317A3 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
TW200621764A (en) Substituted hydantoins
TNSN98238A1 (en) NEW MACROLIDES
TNSN00007A1 (en) NOVEL MACROLIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MXPA03011546A (en) New use.
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
HUP0100566A2 (en) Novel erythromycin derivatives
EA200601607A1 (en) SULPHONAMIDE CONNECTIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
WO2005037839A8 (en) Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof
MA25656A1 (en) A METHOD FOR MAINTAINING OR IMPROVING MUCIN SYNTHESIS.
EA200300066A1 (en) DERIVATIVES OF AMINOALCOXIBENZYL-BENZOFURANE OR BENZOTHIOPHENE, METHOD FOR THEIR PRODUCTION AND THEIR COMPOSITIONS
MXPA05007339A (en) Alpha-aminoamide derivatives useful as antimigraine agents.
WO2007019078A3 (en) Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
YU58102A (en) A method for maintaining or improving the synthesis of mucins
NO20014788D0 (en) A composition for lowering the concentration of pathogenic intestinal peptides
WO2005021575A3 (en) Bacterial signaling molecules that down-regulate pathogenic bacterial virulence properties
DE602004019500D1 (en) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
TW200504036A (en) Novel lactams and uses thereof
FR2874912A1 (en) INTERIOR CLAYS